1. Abstract
Purpose Conventional clinical acoustic analysis systems are confined to specialized clinical environments, which limits scalable and remote voice monitoring. This study aimed to validate LIS-N, a web-based prototype of a novel mobile application that uses the open-source Praat-Parselmouth library for acoustic feature extraction, against the Computerized Speech Lab (CSL), the clinical reference standard, to assess its potential for telehealth and longitudinal voice assessment before integration into clinical or research workflows.
Method Twenty adult volunteers without voice complaints or diagnosed dysphonia completed three voice tasks across three consecutive days at a tertiary academic voice center in quiet isolated rooms. All participants completed the full protocol across three consecutive days. Voice tasks included Rainbow Passage reading, sustained vowel /i/, and maximum phonation time /a/. Audio was captured concurrently using CSL and the LIS-N prototype, which uses Praat-Parselmouth for acoustic feature extraction. To isolate the contributions of recording hardware and analysis software, four cross-system conditions were also examined. Agreement was assessed using Pearson correlation and Bland-Altman analyses. Session-to-session trajectory correlations were computed to evaluate temporal consistency across systems.
Results Fundamental frequency and Pitch Mean demonstrated excellent agreement across all tasks and conditions (r > 0.98), with robustness to hardware and software differences. Pitch Minimum and Pitch Maximum showed strong agreement during sustained vowel tasks. Energy-based features showed moderate agreement, with variability driven primarily by microphone differences, and same-microphone conditions yielded substantially stronger energy agreement. Perturbation measures including jitter, shimmer and CPP showed consistently poor cross-platform agreement, consistent with prior literature.
Conclusion This study provides proof of concept for the viability of open-source acoustic frameworks as accessible alternatives to proprietary clinical systems, while also identifying limitations. Both systems should be interpreted separately, as each remains reliable within its own framework. The LIS-N prototype demonstrated strong agreement for frequency-based voice measures and consistent longitudinal monitoring, supporting adoption of open-source acoustic tools in telehealth and remote voice monitoring.
Competing Interest Statement
The authors have declared no competing interest.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board of the University of South Florida deemed this study exempt and Not Human Research Subject
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵† A full list of Bridge2AI-Voice Consortium members and their affiliations appears at the end of the manuscript.
Data Availability Statement
The data supporting the findings of this study are not publicly available due to participant privacy and confidentiality restrictions. Data access is limited to the approved study team and governed by institutional review requirements.





